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RESEARCH
Clinician identified barriers to treatment 
for individuals in Appalachia with opioid use 
disorder following release from prison: a social 
ecological approach
Amanda M. Bunting1* , Carrie B. Oser1,2, Michele Staton2,3, Katherine S. Eddens4 and Hannah Knudsen2,3
Abstract 
Background: The non-medical use of opioids has reached epidemic levels nationwide, and rural areas have been 
particularly affected by increasing rates of overdose mortality as well as increases in the prison population. Individuals 
with opioid use disorder (OUD) are at increased risk for relapse and overdose upon reentry to the community due to 
decreased tolerance during incarceration. It is crucial to identify barriers to substance use disorder treatment post-
release from prison because treatment can be particularly difficult to access in resource-limited rural Appalachia.
Methods: A social ecological framework was utilized to examine barriers to community-based substance use treat-
ment among individuals with OUD in Appalachian Kentucky following release from prison. Semi-structured qualita-
tive interviews with 15 social service clinicians (SSCs) employed by the Department of Corrections were conducted to 
identify barriers at the individual, interpersonal, organizational/institutional level, community, and systems levels. Two 
independent coders conducted line-by-line coding to identify key themes.
Results: Treatment barriers were identified across the social ecological spectrum. At the individual-level, SSCs 
highlighted high-risk drug use and a lack of motivation. At the interpersonal level, homogenous social networks (i.e., 
homophilious drug-using networks) and networks with limited treatment knowledge inhibited treatment. SSC’s high 
case load and probation/parole officer’s limited understanding of treatment were organizational/institutional barriers. 
Easy access to opioids, few treatment resources, and a lack of community support for treatment were barriers at the 
community level. SSC’s noted system-level barriers such as lack of transportation options, cost, and uncertainty about 
the implementation of the Affordable Care Act.
Conclusions: More rural infrastructure resources as well as additional education for family networks, corrections staff, 
and the community at large in Appalachia are needed to address barriers to OUD treatment. Future research should 
examine barriers from the perspective of other key stakeholders (e.g., clients, families of clients) and test interventions 
to increase access to OUD treatment.
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Background
The prevalence of individuals with an opioid use disor-
der (OUD) has increased over the past decade [1–3]. The 
opioid epidemic has resulted in other negative conse-
quences, including increasing rates of overdose mortali-
ties, emergency room visits, and HIV/HCV prevalence 
[4–6]. It is estimated that from 2001 to 2016, the addi-
tional spending on health care, social services, and the 
criminal justice system coupled with the associated costs 
of loss of lives from overdose have reached 1 trillion dol-
lars [7]. More than half of individuals with OUD have 
contact with the criminal justice system [8], highlighting 
the crucial need to understand treatment access among 
this vulnerable population.
While the entire nation is faced with a public health 
epidemic, certain geographic areas have experienced 
disproportionate levels of OUD, overdose fatalities, and 
HIV/HCV seropositive status [5, 9]. At the epicenter of 
the opioid epidemic is rural Appalachia. The Appalachian 
states of Kentucky, Ohio, and West Virginia rank among 
the top five states for age-adjusted opioid overdose deaths 
[10]. The region also suffers disproportionate rates of 
opioid related HIV and HCV transmission [5, 11] as use 
of opioids exceeds national averages [9, 11, 12]. Despite 
the heavy use of opioids, the economic deprivation spe-
cific to Appalachia (i.e., low formal education, high rates 
of unemployment related to the economy) [11, 13] cre-
ates significant challenges to accessing appropriate care. 
While medications for addiction treatment (MAT) are an 
effective treatment for OUD, Appalachian communities 
face barriers to access similar to other rural areas such 
as lack of prescribing physicians and long waiting lists 
[14–16]. The rurality of Appalachia creates challenges in 
accessing substance use disorder treatment due to inad-
equate transportation [11, 14, 17–19] and a general lack 
of health-related services [19, 20]. These barriers can be 
especially pronounced among re-entering populations 
who already face community reintegration challenges 
[21, 22].
Disproportionate rates of opioid use exist among crimi-
nal justice-involved individuals [23, 24]. Coupled with 
complex substance histories, opioid misuse is associated 
with increased involvement in the criminal justice sys-
tem. OUD is associated with criminal justice involvement 
due to illicit drug use and the co-occurring criminal activ-
ity, as well as through economically motivated crimes to 
obtain opioids [25, 26]. Providing treatment for OUD 
among criminal justice-involved individuals is critical, 
given associated reductions in drug use, crime, and asso-
ciated costs [27, 28]. The need for treatment is ever more 
pressing as individuals returning home from prisons face 
an 129 times greater risk of drug overdose death com-
pared to the general public [29]. However, individuals 
typically return home to limited services; a situation 
exacerbated by limited post-release resources [30, 31]. 
Ensuring recently released populations with substance 
use disorders are matched with appropriate care is a cru-
cial public health concern.
The current study sought to understand the barriers to 
treatment for OUD among individuals reentering com-
munities in Appalachia from clinicians’ perspectives. 
While some research has examined perceived barriers 
to MAT from the perspectives of clinicians and criminal 
justice agencies [32, 33], limited research has considered 
counselor or clinician perspectives to barriers to care in 
rural areas [19, 34, 35], with no known studies consider-
ing the additional vulnerability of criminal justice status. 
To assist in understanding these barriers, the current 
study was guided by the social ecological framework [36, 
37]. The social ecological model of health proposes that 
behavior (i.e., the outcome) is determined by five nested 
levels: intrapersonal factors (i.e., characteristics of the 
individual), interpersonal factors (i.e., social networks), 
institutional factors (i.e., social institutions and organiza-
tions with formal and informal rules), community factors 
(i.e., relationships among organizations and institutions), 
and public policy (i.e., local, state, and national law and 
policies). The social ecological model suggests behav-
ior is influenced by the social environment [37]. Assess-
ing behavioral outcomes as affected by the various levels 
improves opportunities for interventions attuned to the 
appropriate level-specific factors. Utilization of all five 
levels of the framework provides the additional advan-
tage of allowing researchers to assess the interaction of 
various levels and provide more comprehensive sugges-
tions. Many health interventions focus on the individual 
or interpersonal level, and multilevel interventions or 
interventions at upper ecological levels are critically lack-
ing [38]. The current research used the five levels of the 
social ecological model to identify barriers to OUD treat-
ment through qualitative interviews with social service 
clinicians who work with Appalachian individuals re-
entering society after incarceration. These clinicians are 
uniquely qualified to describe such barriers because they 
routinely work with re-entering individuals and provide 
post-release linkages to care.
Methods
Data collection
All social service clinicians (SSCs) employed in Appala-
chian counties in Kentucky (n = 15) were invited to par-
ticipate in the study. The 15 SSCs covered a service area 
of 54 Appalachian counties [39]. SSCs are employed by 
the Kentucky Department of Corrections (DOC) to pro-
vide assessments and referrals to treatment following 
release for substance involved parolees. Typically, SSCs 
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meet with re-entering individuals within 72  h of their 
release. All SSCs who were invited to participate provided 
informed consent and were interviewed. Four of the 15 
SSCs had additional supervisor duties, which includes 
administrative responsibilities and clinical supervision.
Design
Recorded qualitative interviews by a trained interviewer 
took place between January and April of 2017 during reg-
ular office hours, and in the office of the SSC. All inter-
views were conducted by the same interviewer, who has 
a Master’s degree in Public Administration and over a 
decade of experience conducting qualitative interviews 
with DOC staff and administrators on other federally 
funded projects. Interviews were guided by the social 
ecological framework to explore challenges to OUD 
treatment in Appalachia related to client characteristics, 
social networks, the DOC, substance use disorder treat-
ment, and the health care system. SSC’s views on MAT 
were also assessed. Informed consent was obtained and 
interviews averaged 39 min (range: 26–64 min). Partici-
pants were not allowed monetary compensation as part 
of DOC guidelines, thus a picture frame valuing less than 
$20 was provided as a token of appreciation. The study 
was approved by a university’s Institutional Review Board 
and participants were protected by a federal Certificate of 
Confidentiality.
Data analysis
The interviews were transcribed verbatim. Identifying 
information (i.e., names of individuals, cities, counties) 
was removed. Two researchers conducted line-by-line 
coding of each interview independently to generate ini-
tial codes. Consensus was then used to reach agreement 
on the primary codes. Disagreement about codes or 
themes were resolved by discussion among the two cod-
ers and re-review of the original transcripts. Following 
thematic analysis techniques [40], the codes were then 
organized thematically according to the social ecological 
framework.
Results
All respondents were white females, the majority of 
whom had a Master’s degree (73.33%, n = 11). SSCs had 
been employed in their current position for an average of 
5.5 years, with lengths of tenure ranging from 2 months 
to 22 years. One-third (33.3%, n = 5) of the SSCs had pre-
viously been employed in corrections as a parole/proba-
tion or a correctional officer, and a little over one-fourth 
(26.7%, n = 4) had previously worked as a clinician in a 
substance use disorder treatment center.
Individual level barriers
High risk use Several SSCs (n = 5) discussed OUD cli-
ents as being significantly more challenging than clients 
of the past or clients without OUD. Injection drug use 
and the increased risk for overdose made this current 
generation of clients particularly high-risk in the eyes 
of the SSCs. The clinicians also referred to the high 
rate of relapse associated with OUD. Conceptualiza-
tion of their clients as being at high risk of negative 
outcomes was additionally tied to the young age and 
limited life experience of clients, as expressed by one 
SSC supervisor:
And a lot of times they’re high risk substance abuser 
because they tend to use, IV [intravenous] drug 
users a lot of time. And over the course of my career 
it seems like 10  years ago, 15  years ago you would 
not have an IV user until they were in their late 20 s, 
early 30 s. Like we didn’t see it. And now they’re com-
ing into the system at 18 and 19 as an IV drug user.
SSC Supervisor #3
Stigma and lack of motivation Over half (n = 8) of the 
SSCs referred to specific client characteristics as prevent-
ing OUD treatment engagement and subsequent recov-
ery. For these SSCs, clients were stated to be dishonest 
and/or lack the motivation necessary to succeed in 
recovery. Some SSCs stated their clients were unwilling 
to participate, or frequently would use other barriers as 
excuses to not participate in services such as SSC after-
care programs or MAT. Sometimes lack of honesty was 
thought to stem from embarrassment and stigma, espe-
cially among individuals whose OUD developed from a 
legitimate medical need:
I think a lot of times they’re embarrassed and don’t 
want to be honest. There are a lot of clients that 
started out that they were prescribed medications, 
and I think they’re very shocked to find themselves in 
this situation and that’s an embarrassment and they 
don’t want to be honest about that.
SSC # 15
Interpersonal level barriers
Homophilious social networks Most SSCs noted that drug 
use was considered normative among the friends and 
families of clients (n = 12) indicating homophilious social 
networks. Homophily refers to the homogeneity of char-
acteristics among individual’s personal networks [41]. 
Further, networks tended to remain the same pre- and 
post-reentry. This stability of networks, combined with 
normative drug use, was discussed at length by SSCs. The 
homophilious networks threatened clients’ likelihood of 
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recovery, and were observable within the DOC and com-
munity at large, as explained here:
It seems that everyone, everyone they know or associ-
ate with has been or is currently facing the challenge 
of their addiction, the challenges of their addictions 
as well. They don’t have sober friends or a sober sup-
port system. And a lot of it is generational use. Even 
their family are not a good support system because 
it’s been so embedded.
SSC Supervisor #4
Networks have limited knowledge of treatment In addi-
tion to social networks being homophilious, SSCs stated 
that client networks had misperceptions about MAT 
(n = 7), particularly when family members had negative 
perceptions of pharmacotherapy, as illustrated by the fol-
lowing SSC statement:
The families are like, ‘it’s just another drug that 
you’re on, I don’t know why you’re on it, you don’t 
need to be on anything else, you’ve been clean for 
years or months’- however long they stayed in the jail 
or the institution, ‘you don’t need to be on that.’
SSC #14
The normativity of drug use in the clients’ networks 
(i.e., homophilious networks), created a lack of knowl-
edge on how to best promote recovery for clients’ OUD. 
Specifically, it was perceived that the networks and 
clients themselves, do not prioritize certain places or 
behaviors that could best promote recovery among cli-
ents. As explained by one SSC supervisor:
So it’s like, well if they’re not using heroin or if they’re 
not using opioids then alcohol’s not going to hurt 
them because that’s not what got them in trouble, 
or that’s not what they OD’d [overdosed] on. And so 
then what’s the, social norms sometimes get skewed 
by their family. And the farther removed you are 
from having a bigger, I guess network of people to 
associate with, your abnormal looks normal.
SSC Supervisor #3
Thus, the lack of knowledge and perceptions of people 
with whom clients have social relationships after their 
release from prison present challenges not only to access-
ing treatment, but also to succeeding even when treat-
ment was made available.
Institutional and organizational level barriers
High SSC caseload A majority (n = 9) of SSCs stated that 
large caseloads made their job difficult and was a signifi-
cant barrier in providing services to their clients. High 
caseloads, coupled with responsibility for large geo-
graphic areas spread across multiple counties, resulted 
in limited time with each client with months between 
appointments. Consider the struggles as stated by one 
SSC:
However just time to get to your mobile sites is a 
barrier. It takes a lot of time, you’ve got to get up 
early. Even two to three hours earlier. Go there. And 
of course your schedule is full for even next month, 
two months, even three months. So you might have 
someone test positive for heroin or even, let’s say, 
oxycodone- but you don’t see them for two months 
from now.
SSC #14
For this particular SSC, the use of e-mail allowed her to 
close some of the time gaps in her previously two-month 
long waiting list. The SSC utilized e-mail for initial 
assessments to determine if clients needed service rec-
ommendations for clients with active drug use or if cli-
ents were simply complying with DOC regulations and/
or judge mandates to receive an assessment. Other SSCs 
mentioned being accessible by phone or relying on the 
probation and parole officers to assess and screen those 
with the most immediate needs for referral. One SSC 
explained her relationship with the parole and probation 
officers in the following statement:
So I do my best to try to make sure that they [the 
officers] know kind of triage, so they know who needs 
to get on the phone right away, who can wait a week 
and go on my schedule when I make it back to that 
county.
SSC # 10
Lack of parole/probation officer substance use disor-
der education While some SSCs relied on probation 
and parole officers, many discussed the officers lacked a 
general understanding of OUD, treatment options, and 
particularly misunderstood MAT. Ten of the SSCs men-
tioned that probation and parole officers needed more 
education on substance use disorders in general and/or 
MAT. Additionally, four of the SSCs stated probation and 
parole officers would not allow their clients to receive 
MAT. Three of these referred to buprenorphine specifi-
cally, and one discussed prohibition of methadone. One 
SSC explained how she saw the negative perceptions of 
MAT among officers:
Unfortunately, I feel like a lot of the treatment 
around here is just going and getting the medication 
and unfortunately I think that’s where the judges got 
the bad taste in their mouths for  Suboxone® which 
bled over to our officers, because they saw so much 
abuse and so little success stories. But the way it 
works usually, and what I try to tell the officers is, 
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when you have success stories they aren’t walking in 
our offices with new charges because they’re a suc-
cess story so all we see if those clients who are not 
using successfully.
SSC #10
Despite often sharing an office with the probation and 
parole officers, SSCs received completely different train-
ing, and to their knowledge, the officers did not receive 
any training on MAT or substance use disorders. There 
appeared to be a bureaucratic disconnect in who should 
be providing education for the officers, as some SSCs 
mentioned educating officers in their offices while others 
mentioned the need for officers to receive trainings. SSCs 
appeared willing to help officers when presented with 
questions as illustrated by the following SSC when asked 
about her suggestions for improvements:
Education for the clinicians and even the parole 
officers because they play a role in it too. I think 
all of us need to work together and so that we can 
work together for the benefit of the client. Because a 
lot of the officers, don’t even know what it is. They 
was asking me about it earlier this morning-what 
is  Vivitrol®- and I explained it to them, what it is. 
But I think that if they, if their department kind of 
was educated about it, and present to them, it would 
help them more too.
SSC #8
Given the high caseload and many counties of the 
SSCs, it is not unsurprising that a disconnect existed in 
who should be providing education for the officers.
Community level barriers
Three themes related to community level barriers 
emerged in the interviews. Barriers were classified as 
community-level if they were considered to exist as a 
direct result of the Appalachian communities in which 
the clients reside.
Easy access to opioids Three clinicians discussed 
the ease of drug availability as a significant barrier to 
engaging clients in OUD treatment. While not all SSCs 
referred directly to ease of access to opioids as a barrier, 
all but one stated that opioid use was rampant among 
their client caseloads. Some referred to clients who may 
have started with medically necessary prescription opi-
oids and then transitioned to illicit use. One SSC relayed 
the following details, highlighting how economic strain 
among her clients led them to use heroin:
For instance if somebody’s spending three hundred 
eighty dollars a day for four OxyContins and you 
can run up to [large urban city] and get a packet 
of heroin for eighty-five dollars, you know what are 
you going to do. And that lasts a day and a half, 
what are you going to do.
SSC #11
Transitioning from non-medical prescription opioid 
use to heroin is often driven by economic factors and 
availability but has significant public health impacts, 
because the purity of heroin is often unknown which 
can lead to increased risk for overdose.
Limited availability of treatment resources Nearly all 
of the SSCs expressed frustration over the limited avail-
ability of treatment resources in Appalachia (n = 13). 
Limited resources referred to the lack of physicians 
providing treatment, the limited amount of specialty 
inpatient and outpatient treatment programs, long 
waiting lists, and the limited availability of self-help 
group meetings. Often provision of treatment in the 
community was only available through DOC involve-
ment with the support of an SSC, as explained by an 
SSC supervisor:
But if you go to the more rural areas in the Appa-
lachia, it may take you a 20 mile drive to get to 
your closest AA [Alcoholics Anonymous] meeting, 
and that’s at a minimum. If you need a [comor-
bid care center], you have one or two options. 
Inpatient, well it’s not impossible if they’re going 
through us. If they’re going through the Depart-
ment of Corrections we can get them treatment in 
a relatively decent time. But if they’re just a regu-
lar Joe on the streets, it’s really hard.
SSC #1
The SSCs expressed frustration at the lack of 
resources that they faced in rural areas, which were 
particularly acute for individuals with co-occurring 
mental health needs:
This weekend I faced a crisis with a client that was 
terminated from the recovery center due to sui-
cidal ideations, and nobody was at work, and the 
hospital didn’t want to take them. The only crisis 
center would only keep them for 23 h. So here I was 
with a client who has a substance use disorder, 
plus mental health, and there’s no services avail-
able for that client.
SSC Supervisor #4
Lack of community support A few SSCs highlighted a 
unique and potentially important barrier in their rural 
communities. Despite the immense harm caused by 
opioid use in Appalachia, there was the perception that 
in general, communities did not acknowledge OUD as 
a chronic relapsing medical condition and knew lit-
tle about the effectiveness of treatment (n = 5). The 
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perception of substance use disorders in rural commu-
nities was described by one SSC, as follows:
I guess you can say maybe the community perspec-
tive of mental health and substance abuse. It’s the 
elephant in the county that they refuse to see…. 
People don’t perceive it well at all. ‘Just quit, you’re 
an addict.’ It’s not really welcome as much. It’s hard 
go to treatment or to seek treatment when you’re 
embarrassed to even enter a room. And even in 
small counties, you may see a person next to you 
that is your neighbor. That’s even more embarrassing 
in itself.
SSC #14
Not only did the community stigma serve as a barrier, 
but one SSC stated there was little willingness to have 
addiction services located in the communities- a need 
that was critical given the lack of treatment resources, as 
previously discussed.
You know if there is some type of treatment center 
depending on, nobody wants that next to door to 
their business. Nobody wants that next door to 
their neighborhood, whatever type of treatment it 
is because then you got the folks that loiter outside, 
and they smoke. And so then it becomes a barrier to 
providing resources.
SSC Supervisor #3
System level barriers
Lack of transportation All but one (n = 14) of the SSCs 
mentioned transportation was a significant barrier to 
their clients accessing treatment in the community upon 
release, particularly the lack of public transportation. 
Rural clients often were forced to rely on family networks 
for transportation to appointments, which can be even 
more problematic given the distance and rough terrain to 
reach providers in Appalachian counties. This was often 
cited as a source of stress for both the client and the fam-
ily, as described in the following:
Transportation is a big deal. Even if I have a client 
whose nearest provider is the next county, which may 
only be twenty minutes or something twenty miles, 
we don’t have mass transit so everyone can’t just hop 
on a bus and get a ride. And a lot of the time some of 
the providers are actually in some of the more rural 
counties. So there’s no reason for grandma to have to 
go to the store in that county and thus give them a 
ride to that area…. So if there’s not a reason for them 
to go to that county, then they don’t have a ride there 
and so even if we can go through the steps of getting 
them an appointment, and getting their medical 
insurance signed up, and getting them an appoint-
ment- then a lot of times their ride falls through.
SSC # 10
Limited transportation was primarily explained as a 
result of rural sprawl. SSCs also noted that many of their 
clients lacked a driver license and most experienced eco-
nomic strain, which meant the entire household shared 
one car. Individuals were also limited due to the lack of 
public transportation in their communities:
Even if you’re highly motivated there’s not a bus to 
get on. Someone has to have a car and they have to 
be willing, and they have to be willing on the day 
that you need them to go.
SSC Supervisor # 3
As the quote above illustrates, the lack of public trans-
portation was perceived as a source of strain and poten-
tially de-motivating even among the most motivated 
individuals. However, SSCs also mentioned the lack of 
driver licenses and reliance on social networks for rides, 
indicating a fluidity of this barrier as both occurring on 
the individual level yet strained by larger system struc-
tures in Appalachia.
Treatments are cost prohibitive OUD treatments 
were often viewed as cost prohibitive for clients, in part 
because of larger healthcare and pharmaceutical infra-
structure issues. Ten of the SSCs mentioned treatment 
was hard to obtain due to cost, and the majority of these 
referred specifically to MAT, as discussed by one SSC 
when asked about the lack of use of MAT by her clients:
Well I think one, is the cost. Unfortunately I don’t 
think many know about all of the options for the 
medically assisted [treatment]. It’s primarily just the 
common  Suboxone® and methadone and those are 
very expensive generally. They just can’t afford that. 
I’ve had several start in that program. And I mean, 
300 to 400 dollars a month, that’s just very hard to 
maintain.
SSC #15
Uncertain future of the Affordable Care Act (ACA) 
While all of the SSCs mentioned insurance in some 
capacity, some situated their comments within a con-
text of the Medicaid program, Kentucky’s expansion of 
Medicaid to cover uninsured low-income adults, and 
the ACA. Nine of the SSCs mentioned how changes to 
insurance, ease of Medicaid enrollment, or the ACA spe-
cifically improved access to care for their clients, as illus-
trated here:
Before we had changes with the insurance we would 
have trouble finding payer sources. But the change in 
the Affordable Care Act helped with that.
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SSC Supervisor #4
At the time of the interviews, the nation was in the 
midst of the new presidency of Donald Trump who 
made a campaign promise to repeal the Affordable Care 
Act, and during data collection, the US Congress voted 
on a number of measures to change the ACA. This was 
reflected in some of the interviews, as SSCs perceived 
changes to the current system as a future barrier to 
access for clients:
Right now it’s really good [the health care system] 
because they’re eligible for health insurance but if 
that changes that will really effect what they’re eligi-
ble for and really will affect our job and what we can 
do for them.
SSC #6
Discussion
This study of SSCs in Appalachian communities found 
several barriers to treatment for individuals with OUD. 
These barriers were identified at the levels of individuals, 
interpersonal networks, institutions and organizations, 
the community, and systems within the social ecological 
model. Examination of the barriers within this frame-
work provided a nuanced method to promote sugges-
tions for reducing barriers.
At the individual level, clinicians identified their clients 
as high-risk users who were often unmotivated to engage 
in treatment. Injection drug use practices facilitates the 
transmission of bloodborne infections (e.g., HIV, HCV), 
and this concern was noted among the SSCs. Young per-
sons who inject drugs may be at increased risk of infec-
tions, owing to sharing needles and drug preparation 
equipment with sexual partners or pooling money to buy 
drugs and consequent needle sharing [42, 43]. One of the 
SSCs mentioned the youth and limited life experiences of 
their high-risk clients, and research suggests understand-
ing the social context and relationships of young persons 
who inject drugs could assist in lowering risk among this 
population [42]. Extant research has indicated motivation 
represents a challenge to getting individuals to access 
care [44]. However, this research has also demonstrated 
that those who may be ‘least motivated’ typically have 
the most chronic health problems including injection 
drug use [44]. Thus while perceived as stigma and lack 
of motivation by SSCs, there could be some individuals 
who have become disenfranchised with the lack of ser-
vices available to them or a feeling of being caught in the 
criminal justice system which is not primarily focused on 
treatment. Perceived lack of motivation could also stem 
from stigma and embarrassment for individuals who first 
started using prescription medications stemming from 
legitimate medical concerns before progressing to misuse 
and OUD.
Network level barriers included homophilious client 
networks with limited substance use disorder treatment 
knowledge among network members. The SSC-client 
relationship could be expanded to include conversation 
or even take-home educational resources for families in 
order to help educate client networks. A network-based 
intervention could promote SSCs as social influencers 
who facilitate treatment, recovery, and healthy lifestyles 
not only for their clients, but also have trickle-down posi-
tive effects to their client’s networks. However, the insti-
tutional and organizational barriers of high SSC caseload 
and travel burdens would need to first be overcome in 
order for SSCs to have the availability and resources to 
provide such an intervention.
Institutional and organizational barriers included high 
SSC caseload and lack of probation/parole officer edu-
cation about OUD. Institution specific barriers to the 
DOC (e.g., caseload) would require additionally allocated 
resources to reduce burden for SSCs. Additionally, a clear 
and perhaps easy to accomplish improvement would 
be the provision of substance use education, to include 
MAT, for probation and parole officers. A general edu-
cation seminar would take little resources or time away 
from officer supervision duties and could be added to 
current training mandates. Provision of education to 
overcome discrepancies in employee education is par-
ticularly important given the findings that often the DOC 
was one of the only service providers available in rural 
counties. The education of officers may assist with revers-
ing the prohibition of MAT by some officers. At a more 
institutional level, the SSCs reported that judges also pro-
hibited the use of MATs and overcoming this challenge 
would require the support of DOC, as well as possibly 
state legislation in a more comprehensive approach.
At the community level, SSCs reported that the com-
munity lacked both treatment resources and community-
level support. The lack of treatment resources in rural 
areas is by no means a new phenomenon. In addition 
to the support for the use of telemedicine in rural areas, 
certain advances in MAT may be advantageous for indi-
viduals with OUD who would benefit from MAT as part 
of their treatment plan [14]. The advent of time-release 
formulas (e.g.,  Sublocade®,  Vivitrol®) may reduce the 
frequency of transportation barriers for eligible individu-
als. Combined with telemedicine for psychosocial coun-
seling, rural clients could fare better even in the face of 
reduced community resources.
Previous research has found health care providers have 
reported difficulties in building community relationships 
in rural areas [45]. Similar to suggestions for overcoming 
physician community distrust, SSCs who live and actively 
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participate in their communities in informal ways (e.g., 
church, local festivals) may be presented with informal 
opportunities to educate the community [45]. More for-
mal ways to educate the community could include the 
DOC encouraging and providing time for SSCs, or even a 
specified community liaison, to be present at community 
events in more formal capacities (e.g., educational booth, 
hosting an event, inter-agency collaborations with public 
health departments).
Related to community support was the potential for 
community stigma. Rural clients are more likely to have 
concerns related to confidentiality due to smaller net-
works [18, 20]. As one author stated, rural communities 
are like “fishbowls” in that the attendance at treatment 
is observed by community members, and privacy can 
be difficult to protect [34]. Integrating treatment such 
as MAT into primary care settings could assist with this 
barrier. Further, increased general education for the com-
munity could assist in removing the social stigmas asso-
ciated with substance use disorders, similar to public 
health approaches of education for other chronic health 
conditions (e.g., diabetes, heart disease).
The ease of access to opioids also presented a challenge 
to clients’ treatment. This challenge has been reported 
nationwide, but can be particularly pronounced in areas 
where nonmedical prescription pain relievers offer a 
form of social capital [46], as spurred by the years of ‘pill 
mills’ proliferating rural areas. Further, nationwide trends 
indicate that cost, ease of access, and policy have resulted 
in transition from nonmedical prescription pain relievers 
to less expensive heroin [47, 48]. This issue of supply and 
access is one that still remains to be addressed via policy 
and law enforcement efforts.
Finally, at the systems level, the barriers to care identi-
fied by SSCs included lack of transportation, high-cost of 
treatments, and uncertainty of the ACA. Having a driv-
er’s license has been shown to significantly increase the 
likelihood of health care utilization [17]. Lack of a license 
among clients may not be due to individual character-
istics, but rather due to systemic issues such as cost or 
statutory prohibition of licensing [49]. Provision of rides 
from family and friends also increases the likelihood of 
chronic care visits; [17] however, as network barriers here 
indicate, social networks may not always perceive OUD 
as a chronic health condition in need of care and sup-
port. Access to transportation could be improved in rural 
areas, if current medical transportation that is often lim-
ited to older or disabled adults was expanded to include 
the current OUD and other substance use disorder pop-
ulations. However, even these options are not without 
significant barriers [17] (e.g., expensive to counties, time-
consuming). New advances in telemedicine could be par-
ticularly important among rural individuals with OUD 
[50]. Since telehealth still carries potential infrastructure 
and cost burdens, the use of mobile treatment providers 
would be additionally beneficial.
While the high cost of treatment has been noted by 
other research, [15, 20] a novel contribution of the cur-
rent interviews was the SSCs perspective and concern 
over the ACA. While the individual mandate portion of 
the ACA was repealed in October 2017, the ACA and 
the portions related to Medicaid remain unchanged as of 
this writing. Studies continue to find the ACA has ben-
eficial effects through uninsured rate reductions among 
vulnerable populations [51] and in rural areas [52, 53]. 
Policymakers who are dedicated to addressing the opi-
oid epidemic should continue to support the ACA and 
expansion of treatment resources.
This study was not without limitations, which future 
research should consider. The study only assessed barri-
ers as perceived by SSCs, a critical perspective given their 
role yet additional barriers may be perceived from the 
perspectives of clients. The perceptions of clinicians may 
be biased, incomplete, or out of touch with the everyday 
lived experiences of the clients served. It is also possible 
the responses were biased as a result of the SSC’s pro-
jecting desired outcomes that were not reflective of all 
stakeholders. This study was limited to SSCs in one geo-
graphic location—Appalachian Kentucky. While all SSCs 
in this area were included in the study, the sample size 
was limited. Future research should consider the cultural 
nuances of other rural locations, such as the Mississippi 
Delta or the rural Southwest. Treatment needs and bar-
riers to access may differ for people released from prison 
to other rural regions of the U.S. In addition, there is 
wide-variation in the operating procedures of each state’s 
Department of Corrections, some of which may not have 
staff who serve in a role similar to Kentucky DOC’s SSC. 
However, Kentucky DOC has implemented several inno-
vations to address the treatment needs of people who are 
under criminal justice system supervision. These strate-
gies include establishing SSC positions to promote link-
ages to behavioral health services at re-entry, offering 
extended release naltrexone in prison and jail at re-entry 
for clinically eligible clients who completed a correctional 
substance use disorder treatment program, and establish-
ing Recovery Kentucky which created 13 community-
based centers to provide housing and recovery services 
for 2000 Kentuckians simultaneously. It is important 
to keep in mind the varying educational foundations 
that were found to exist within this system, and future 
research could consider how perspectives and services 
vary by SUD training and education. In addition to iden-
tification of barriers from the perspective of others (e.g., 
clients, probation and parole officers), future research 
should consider interventions that seek to overcome the 
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barriers identified. For example, the use of telemedicine 
services as well as mobile treatment providers could be 
particularly advantageous in rural communities. Network 
and community-level interventions focused on education 
of OUD and MAT would additionally be beneficial.
Conclusions
The current study offered the perspective of clinicians 
in assessing the barriers to treatment for opioid use 
in resource-limited Appalachian Kentucky. Through 
utilization of the social ecological framework, these 
barriers were situated as individual, interpersonal, 
institutional/organizational, community, and system-
level. The SSCs in Appalachian Kentucky cited barriers 
to treatment to include:, high risk use, stigma and lack 
of motivation, homophilious networks, networks with 
limited knowledge of treatment, high caseloads, lack 
of substance use disorder education for parole/proba-
tion officers, limited availability of treatment resources, 
ease of access to opioids, lack of community support, 
lack of transportation, cost prohibitive treatments, and 
an uncertain future of the Affordable Care Act. Iden-
tification of these barriers from the perspective of 
DOC employed SSCs was critical, as these clinicians 
are directly responsible for post-release referrals and 
after-care services. Identified suggestions provide real-
world opportunities for improving access to treatment 
in Appalachia.
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